Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Autoantibodies to Glutamate Receptor Antigens in Multiple Sclerosis and Rasmussen's Encephalitis.
Variations in predicted risks in personal genome testing for common complex diseases.
[Therapeutic use of cannabis derivatives].
Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report.
A quantitative evaluation of damage in normal appearing white matter in patients with multiple sclerosis using diffusion tensor MR imaging at 3 T.
The link between multiple sclerosis and depression.
Adult myelination: wrapping up neuronal plasticity.
Intraspinal transplantation of mouse and human neural precursor cells.
Bedside tested ocular motor disorders in multiple sclerosis patients.
Neurological disorders and inflammatory bowel diseases.
Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theory.
Should Plasma Exchange Be Offered to Patients With Multiple Sclerosis-Associated Optic Neuritis?
Emotional dysfunctions in neurodegenerative diseases.
A decade from discovery to therapy: Lingo-1, the dark horse in neurological and psychiatric disorders.
Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study.
Indices of Cognitive Dysfunction in Relapsing-Remitting Multiple Sclerosis: Intra-individual Variability, Processing Speed, and Attention Network Efficiency.
Do not judge a cell by its cover-diversity of CNS resident, adjoining and infiltrating myeloid cells in inflammation.
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains.
Lesion Activity on Brain MRI in a Chinese Population with Unilateral Optic Neuritis.
Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment.
Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry.
Contribution of pannexin1 to experimental autoimmune encephalomyelitis.
Emerging stem cell therapies: treatment, safety, and biology.
Central nervous system involvement in primary Sjogren`s syndrome manifesting as multiple sclerosis.
Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
Pages
« first
‹ previous
…
500
501
502
503
504
505
506
507
508
…
next ›
last »